Study in Patients With Primary Breast Diffuse Large B-cell Lymphoma
clinical trial
Press Enter · cited answer in seconds
0 sources
Summary
Study in Patients With Primary Breast Diffuse Large B-cell Lymphoma is a clinical trial[1].
Key Facts
- Study in Patients With Primary Breast Diffuse Large B-cell Lymphoma's instance of is recorded as clinical trial[2].
- Study in Patients With Primary Breast Diffuse Large B-cell Lymphoma's start time is recorded as +2011-08-31T00:00:00Z[3].
- Study in Patients With Primary Breast Diffuse Large B-cell Lymphoma's end time is recorded as +2019-08-31T00:00:00Z[4].
- Study in Patients With Primary Breast Diffuse Large B-cell Lymphoma's sponsor is recorded as Jeonbuk National University Hospital[5].
- Study in Patients With Primary Breast Diffuse Large B-cell Lymphoma's main subject is recorded as lymphoma[6].
- Study in Patients With Primary Breast Diffuse Large B-cell Lymphoma's number of participants is recorded as {'unit': '1', 'amount': '+33'}[7].
- Study in Patients With Primary Breast Diffuse Large B-cell Lymphoma's title is recorded as Multi-center Phase II Study of the Combination of R-CHOP (RItuximab Plus Cyclophosphamide, Adriamycin, Vincristine, and Prednisolone) and Prophylactic Intrathecal Chemotherapy With Methotrexate in Patients With CD20+ Primary Breast Diffuse Large B-cell Lymphoma[8].
- Study in Patients With Primary Breast Diffuse Large B-cell Lymphoma's minimum age is recorded as {'unit': 'http://www.wikidata.org/entity/Q577', 'amount': '+20'}[9].
- Study in Patients With Primary Breast Diffuse Large B-cell Lymphoma's ClinicalTrials.gov ID is recorded as NCT01448096[10].
- Study in Patients With Primary Breast Diffuse Large B-cell Lymphoma's maximum age is recorded as {'unit': 'http://www.wikidata.org/entity/Q577', 'amount': '+75'}[11].
- Study in Patients With Primary Breast Diffuse Large B-cell Lymphoma's research intervention is recorded as (RS)-cyclophosphamide[12].
- Study in Patients With Primary Breast Diffuse Large B-cell Lymphoma's research intervention is recorded as methotrexate[13].
- Study in Patients With Primary Breast Diffuse Large B-cell Lymphoma's research intervention is recorded as rituximab[14].
- Study in Patients With Primary Breast Diffuse Large B-cell Lymphoma's research intervention is recorded as vincristine[15].
- Study in Patients With Primary Breast Diffuse Large B-cell Lymphoma's clinical trial phase is recorded as phase II clinical trial[16].
- Study in Patients With Primary Breast Diffuse Large B-cell Lymphoma's research site is recorded as Jeonbuk National University[17].
- Study in Patients With Primary Breast Diffuse Large B-cell Lymphoma's research subject recruitment status is recorded as completed[18].
- Study in Patients With Primary Breast Diffuse Large B-cell Lymphoma's study type is recorded as interventional study[19].